MedTrace Logo

Impact of Three Continuing Education Meetings for Community Pharmacists on Weight Management

NCT01339364 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2011-07-26

No results posted yet for this study

Summary

This study is a three-arm randomized controlled trial to evaluate the effects of 1-day continuing educational meetings for community pharmacists with three distinct educational methods: 1) Didactic lecture 2) Didactic lecture plus case discussion in a large group 3) Didactic lecture plus small group education with simulated patient

Knowledge and attitude of the participants would be measured as the study outcome in three periods: pre-education, post-education and 1 month after the meetings.

Conditions

  • Continuing Pharmacy Education
  • Obesity

Interventions

OTHER

Didactic Lecture

2 sessions of didactic lecture with PowerPoint presentations each delivered by a special lecturer. whole education period lasts 3 hours.

OTHER

Interactive Lecture

2 sessions of brief interactive lectures followed by case discussion sections.

OTHER

Lecture plus Small Group Education

A 1.5 hours session of didactic lecture followed by a session of small group education with 3 simulated patients.

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Kheirollah Gholami, M.Sc, PharmD · Tehran University of Medical Sciences

  • Arash Rashidian, MD, PhD · Tehran University of Medical Sciences

  • Mohammadreza Javadi, PharmD, BCPS · Tehran University of Medical Sciences

  • Amir Sarayani, PharmD, MPH · Tehran University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-05-31
Completion
2011-06-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01339364 on ClinicalTrials.gov